PHENYTOIN AS A PROBE OF DRUG-METABOLISM - PREDICTING CLEARANCE WITH A SALIVARY SAMPLE

被引:15
作者
BACHMANN, K
SCHWARTZ, J
FORNEY, R
JAUREGUI, L
机构
[1] MED COLL OHIO,TOLEDO,OH 43699
[2] ST VINCENT MED CTR,TOLEDO,OH
关键词
D O I
10.1159/000138063
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
引用
收藏
页码:145 / 152
页数:8
相关论文
共 16 条
[1]   SELECTIVITY OF CHOLESTYRAMINE TREATMENT ON HEPATIC MIXED-FUNCTION OXIDASE ACTIVITY [J].
BACHMANN, K ;
SCHWARTZ, J ;
FORNEY, R ;
SHERMAN, G ;
JAUREGUI, L .
PHARMACOLOGY, 1984, 29 (03) :128-141
[2]   MONITORING PHENYTOIN IN SALIVARY AND PLASMA ULTRAFILTRATES OF PEDIATRIC-PATIENTS [J].
BACHMANN, K ;
FORNEY, RB ;
VOELLER, K .
THERAPEUTIC DRUG MONITORING, 1983, 5 (03) :325-329
[3]   THEOPHYLLINE KINETICS - DOSE DEPENDENCY AND SINGLE SAMPLE PREDICTION OF CLEARANCE [J].
BACHMANN, K ;
SCHWARTZ, J ;
FORNEY, R ;
JAUREGUI, L .
PHARMACOLOGY, 1985, 30 (03) :136-144
[4]  
BENET LZ, 1984, PHARMACOKINETIC BASI
[5]  
BROWN RD, 1978, J PHARM SCI, V76, P1687
[6]   OPTIMAL SAMPLING TIMES FOR MINIMUM VARIANCE OF CLEARANCE DETERMINATION [J].
DOSSING, M ;
VOLUND, A ;
POULSEN, HE .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 15 (02) :231-235
[7]   A SIMPLE METHOD FOR DETERMINATION OF ANTIPYRINE CLEARANCE [J].
DOSSING, M ;
POULSEN, HE ;
ANDREASEN, PB ;
TYGSTRUP, N .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 32 (03) :392-396
[8]   PHENYTOIN METABOLISM IN SUBJECTS WITH LONG AND SHORT PLASMA HALF-LIVES [J].
GLAZKO, AJ ;
PETERSON, FE ;
CHANG, T ;
DILL, WA ;
SMITH, TC ;
BUCHANAN, RA .
THERAPEUTIC DRUG MONITORING, 1982, 4 (03) :281-292
[9]  
GUGLER R, 1976, CLIN PHARMACOL THER, V19, P135
[10]   QUANTITATIVE ASSESSMENT OF HEPATIC FUNCTION BY BREATH ANALYSIS AFTER ORAL-ADMINISTRATION OF [AMINOPYRINE-C-14 [J].
HEPNER, GW ;
VESELL, ES .
ANNALS OF INTERNAL MEDICINE, 1975, 83 (05) :632-638